Showing 1,241 - 1,260 results of 2,124 for search '"Dermatology"', query time: 0.06s Refine Results
  1. 1241
  2. 1242
  3. 1243
  4. 1244
  5. 1245

    Assessing the Short-Term Efficacy and Safety of Guselkumab for Moderate-to-Severe Plaque Psoriasis: Meta-Analysis of Randomized Controlled Trials by Jing Yang, Zongming Wang, Xilin Zhang

    Published 2020-01-01
    “…The results indicated that guselkumab had better efficacy than placebo or adalimumab for Psoriasis Area and Severity Index score reductions from baseline of 75% (PASI 75) (OR=61.37, 95% CI=31.15 to 120.91; OR=3.08, 95% CI=2.35 to 4.06), Investigator’s Global Assessment scores of 0 or 1 (IGA 0/1) (OR=65.75, 95% CI=45.54 to 94.95; OR=2.79, 95% CI=2.17 to 3.59), and Dermatology Life Quality Index scores of 0 or 1 (DLQI 0/1) (OR=29.64, 95% CI=18.80 to 46.73; OR=1.86, 95% CI=1.50 to 2.31). …”
    Get full text
    Article
  6. 1246
  7. 1247
  8. 1248
  9. 1249
  10. 1250
  11. 1251
  12. 1252
  13. 1253
  14. 1254
  15. 1255
  16. 1256
  17. 1257
  18. 1258
  19. 1259
  20. 1260